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It is extremely important for the health to understand the regulatory mechanisms of
energy expenditure. These regulatory mechanisms play a central role in the pathogenesis
of body weight alteration. The hypothalamus integrates nutritional information derived
from all peripheral organs. This region of the brain controls hormonal secretions and
neural pathways of the brainstem. Orexin-A is a hypothalamic neuropeptide involved
in the regulation of feeding behavior, sleep-wakefulness rhythm, and neuroendocrine
homeostasis. This neuropeptide is involved in the control of the sympathetic activation,
blood pressure, metabolic status, and blood glucose level. This minireview focuses on
relationship between the sympathetic nervous system and orexin-A in the control of eating
behavior and energy expenditure. The “thermoregulatory hypothesis” of food intake is
analyzed, underlining the role played by orexin-A in the control of food intake related to body
temperature. Furthermore, the paradoxical eating behavior induced orexin-A is illustrated
in this minireview.
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INTRODUCTION
Obesity and diabetes are a worldwide public health issue with
extensive medical, social, and economic consequences (Yach et al.,
2006; Runge, 2007). Obesity (body mass index ≥30 kg of body
weight/m2 of height) has negative effects on health and increases
the risk of developing a variety of diseases, including cardio-
vascular syndromes, some cancers, and diabetes mellitus (Must
et al., 1999; Field et al., 2001; Calle et al., 2003; Friedenberg et al.,
2008). Over the past three decades, the prevalence of obesity
has doubled in the USA and in Europe (Ogden et al., 2006; Van
Vliet-Ostaptchouk et al., 2014). Although according to the most
recent data published in the 2005–2006 update of the National
Health and Nutrition Examination Survey (NHANES) obesity
rates have stabilized, others (Wang and Beydoun, 2007) expect
that the obesity “epidemic” will only continue to worsen, with
as many as 75% of Americans and of Europeans potentially
being overweight in the year 2020. Physicians will undoubtedly
encounter obese people in clinical practice and must, then, be
able to identify and address care needs speciﬁc to this patient
population.
This minireview focuses on relationship between the auto-
nomic nervous system and orexin-A in the control of eating
behavior, energy expenditure, and body weight regulation. The
“thermoregulatory hypothesis” of food intake (Himms-Hagen,
1995) is analyzed, underlining the role played by orexin-A in the
control of eating behavior related to body temperature.
ENERGY HOMEOSTASIS
Energy homeostasis is determined by the balance between
intake of calories and energy expenditure. This is regulated by
interconnected neuroendocrine and autonomic pathways (Monda
et al., 2008a).
Resting energy expenditure (REE) accounts for 60–75% of
total daily energy expenditure. Several factors contribute to the
inter-individual variability in REE such as fat-free mass (FFM;
Weyer et al., 1999), sympathetic nervous system (SNS) activity
(Welle et al., 1991; Messina et al., 2012), and endocrine sta-
tus [e.g., thyroid hormone (Danforth and Burger, 1984)]. REE
decreases with age (Roubenoff et al., 2000). This decline is due
not only to the loss of FFM and an alteration in its metabol-
ically active components, but also to the reduction in physical
activity.
HYPOTHALAMUS AND OREXINS
The hypothalamus, a key component for regulation of energy
homeostasis, continuouslymonitors signals that reﬂect energy sta-
tus and initiates appropriate behavioral and metabolic responses
(Suzuki et al., 2012). It controls glucose utilization in insulin-
sensitive organs, such as skeletal muscle, as well as whole-body
energy metabolism (Sudo et al., 1991; Haque et al., 1999).
Orexins A and B are hypothalamic neuropeptides, involved in
the regulation of feeding behavior, sleep-wakefulness rhythm, and
neuroendocrine homeostasis (Kukkonen et al., 2002; Monda et al.,
2005; Viggiano et al., 2006), as reported in Figure 1.
These peptides derive from the prepro-orexin (preprohypocre-
tin) gene, which encodes a precursor (130 amino acids in
rodents, 131 residues in humans) that is cleaved into orexin-A
(synonymous with hypocretin-1; 33 amino acids) and orexin-B
(hypocretin-2; 28 residues; Sakurai et al., 1998). Orexins pro-
mote both arousal and feeding (Sweet et al., 1999). Orexin-A binds
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FIGURE 1 | Effects of orexins in peripheral tissue and central nervous
system.
to two G-protein-coupled receptors, orexin receptor-1 (hypocre-
tin receptor-1) and orexin receptor-2 (hypocretin receptor-2).
The expression pattern of mRNA encoding two orexin recep-
tors (OX1R andOX2R) in the rat’s brain has been demon-
strated (Trivedi et al., 1998; Machaalani et al., 2013). Within
the hypothalamus, expression for the OX1R mRNA was largely
restricted in the ventromedial (VMH) and dorsomedial hypotha-
lamic nuclei, while paraventricular nucleus, VMH, and arcuate
nucleus contain high levels of OX2R mRNA, as well as in
mammillary nuclei (Zhang et al., 2005). Lu et al. (2000) have
demonstrated that levels of OX1R mRNA signiﬁcantly increased
in the VMH of rats after 20 h of fasting. An initial decrease
(14 h) and a subsequent increase (20 h) in OX1R mRNA
levels after fasting were observed in the dorsomedial hypotha-
lamic nucleus. Levels of OX2R mRNA increased in the arcuate
nucleus, but they didn’t change in the dorsomedial hypothala-
mic nucleus and paraventricular hypothalamic nucleus following
fasting (Lu et al., 2000).
Orexin neurons may also functionally interact with glucose-
sensitive neurons in the hypothalamus, notably the glucose-
responsive cells (glucose-excited neurons: stimulated by rising
glucose levels) found predominantly in theVMH, and the glucose-
sensitive neurons (glucose-inhibited neurons: stimulated when
glucose falls) that constitute 30% of lateral hypothalamic area
(LHA) neurons. There are synaptic contacts between orexin neu-
rons and glucose-sensitive cells in the LHA (Shiraishi et al., 2000),
while orexin-A speciﬁcally stimulates the glucose-sensitive cells
(Liu et al., 2001). On the contrary, orexin-A inhibits glucose-
responsive neurons in the VMH (Shiraishi et al., 2000). Muroya
et al. (2001) suggest that some glucose-sensitive neurons express
orexins. In the medulla, orexin neurons innervate not only
the ventral area (Zheng et al., 2005), but also the nucleus of
the solitary tract (Ciriello et al., 2003), which is an impor-
tant relay station that receives sensory signals, such as portal
vein glucose availability and gastric distension from the viscera.
These signals are conveyed to the hypothalamus (Horst et al.,
1989).
Sugar-sensing neurons exist in restricted brain regions, such
as hypothalamus and brain stem, and they are classiﬁed into
two groups, called glucose-excited (GE) neurons and glucose-
inhibited (GI) neurons, in terms of the mode of response to
extracellular glucose changes within physiological cerebrospinal
ﬂuid (CSF) range (Burdakov and González, 2009; Gonzàlez
et al., 2009). For instance, orexin neurons in the LHA and neu-
ropeptide Y (NPY)/agouti-related peptide (AgRP) neurons in
the ARC are glucose-inhibited, whereas melanin-concentrating
hormone (MCH) neurons in LHA and proopiomelanocortin
(POMC) neurons in the ARC are glucose-excited (Burdakov
et al., 2005; Burdakov and González, 2009). The sugar sens-
ing of orexin neurons, which is a major class of GI neu-
rons, is metabolism-independent, since the glucose response is
unaffected by glucokinase inhibitors, and mimicked by a non-
metabolizable glucose analog 2-deoxyglucose (González et al.,
2008), although the accurate mechanisms, particularly the func-
tional molecules relevant to glucose-induced inhibition, have
not yet been explained. Orexin neurons are not inhibited by L-
glucose, galactose, α-methyl-D-glucoside, or fructose, whereas
GE neurons can sense galactose. More recently, it has been
suggested that orexin neurons function as a “conditional glu-
cosensor,” because the electrical activity of orexin neurons is
more potently inhibited by glucose when intracellular energy
levels (i.e., cytosolic levels of pyruvate, lactate, or ATP) are
low, whereas high energy levels attenuate the glucose response
in orexin neurons (Venner et al., 2011). Besides, Yi et al. (2009)
have reported that a continuous intracerebroventricula (ICV)
infusion of orexin-A (1 mmol/L, 5 μL/h) into rats fasted for
5 h brought about an increase in plasma glucose levels, and
prevented a daytime decrease of endogenous hepatic glucose pro-
duction (EGP). Hepatic sympathetic, but not parasympathetic,
denervation blocked the orexin induced apparent enhancement
of EGP.
In addition, when the γ-aminobutyric acid receptor antagonist
bicuculline was administered in the perifornical area in order to
activate orexin neurons, basal EGP was increased, and insulin-
mediated suppression of EGP was attenuated, but the insulin-
induced glucose disposal was enhanced (Yi et al., 2009).
In addition, the presence of orexin receptors in other cerebral
areas suggests that orexin-A plays additional functions (Kukko-
nen et al., 2002). It has been demonstrated that the orexins
play a role in sleep regulation (Beuckmann and Yanagisawa, 2002).
Deﬁciency in orexin neurotransmission results in the sleep
disorder narcolepsy in mice, dogs, and humans (Monda
et al., 2004a). Orexin derangements in patients with narcolepsy
were associated with an increased body mass index (Schuld
et al., 2000) and a higher risk of type-II diabetes mellitus
(Honda et al., 1996).
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Orexins exert peripheral effect and this was suggested by the
detection of substantial levels of orexins in plasma (Adam et al.,
2002), as well as the presence of orexin receptors in several periph-
eral tissues, including the gastrointestinal tract (GIT), endocrine
pancreas, adrenal glands, and adipose tissue (Digby et al., 2006;
Heinonen et al., 2008).
Snow et al. (2002) have demonstrated that plasma orexin lev-
els are one-ﬁfth to one-eighth of orexin CSF values. However,
the source of orexin in peripheral tissue is still unclear. Is orexin
directly released into the blood stream or leaked from the CSF?
One possibility is that orexin is released from the brain. The other
possibility is that orexin is produced directly in peripheral tissues.
Orexin-immunoreactive cells are observed in the gastrointestinal
tract and pancreas. However, the question of orexin synthe-
sis in peripheral tissue is still under discussion. Further studies
are needed to better understand orexin physiology in peripheral
tissues.
The inﬂuence of orexin-A on metabolic status and plasma
glucose level may contribute to increase diabetics morbidity and
mortality (Minokoshi et al., 1999). It has been proved that orexins
affect the plasma lipoprotein proﬁle and insulin glucose home-
ostasis (Muroya et al., 2001). Orexins stimulate insulin release
from pancreatic cells in vivo and in vitro (Nowak et al., 2000).
Several studies have focused on ﬁnding out the relationship
between circulating orexin and fat mass and have proved that
there is a strong correlation between low plasma orexin and obe-
sity (Adam et al., 2002; Messina et al., 2013a). A signiﬁcant issue
is whether this naturally occurring biological peptide “orexin”
in useful in weight management or obesity treatment. Many
suggest that when orexin is peripherally injected, it activates
thermogenesis, without limiting feeding or increasing physi-
cal activity. These encouraging observations have paved the
way for clinical testing of the thermogenic potential of orexin
(Messina et al., 2013b).
Orexin-A controls glucose production and utilization in the
peripheral tissues via the autonomic nervous system (Tsuneki
et al., 2010). These conclusions demonstrate that orexin is involved
in the control of central and peripheral hormonal actions for
the maintenance of glucose homeostasis, though it has been
demonstrated that glucose control remains following decerebra-
tion (DiRocco and Grill, 1979). Existing evidence suggests that
orexins induce glucose production in the liver (Stanley et al., 2010)
and help glucose uptake in skeletalmuscle (Yi et al., 2009). In addi-
tion it has been shown that orexins A and B differentially regulate
glucagon release from pancreas (Bass and Takahashi, 2010).
In summary, there is substantial evidence in the literature that
helps to deﬁne the physiological role of orexin neurons, and their
connections, as reported in Figure 2. For instance, anatomical
works by Kilduff and Peyron (2000) and Kerman (2008); phys-
iological studies by Karnani and Burdakov (2011) and Inutsuka
and Yamanaka (2013) in glucose-regulation, and Morrison et al.
(2012a) in thermoregulation. More recently, opto- and pharmaco-
genetic tools also have been used to investigate the physiological
role of these neurons (Heydendael et al., 2014; Inutsuka et al.,
2014). Finally, hypothalamic orexin neurons co-express glutamate
vesicular transporters (Rosin et al., 2003), suggesting an important
role of this neurotransmitter in the orexinergic pathway.
FIGURE 2 | Factors influencing eating behavior.
THE SYMPATHETIC NERVOUS SYSTEM
Eating is a complex behavior that partly involves the sympathetic
nervous system. This sympathetic involvement is exerted by an
inﬂuenceonbody temperature, in agreementwith the“thermoreg-
ulatory hypothesis” of eating behavior (Himms-Hagen, 1995).
Obviously, the role of the sympathetic system in controlling the
eating behavior is not restricted only to changes in body temper-
ature. For instance, the aforementioned glucose-control involves
the sympathetic system.
Orexin-A also inﬂuences body temperature. In fact, an ICV
administration of orexin-A induces an increase in ﬁring rate of
the sympathetic nerves to BAT, accompanied with a rise in BAT
and colonic temperatures (Monda et al., 2001). The simultaneous
increase in heart rate and body temperature after an ICV injec-
tion of orexin-A shows a generalized activation of the sympathetic
nervous system. Few studies have been made on the topic of the
roles played by different cerebral areas involved in the induction
of the above-mentioned tachycardia and hyperthermia (Monda
et al., 1994, 1995, 1996).
The sympathetic adjustment of thermoregulation also implies
in energy expenditure. The functional organization and neu-
rochemical inﬂuences within the CNS networks governs the
level of BAT sympathetic nerve activity to produce the
thermoregulatory and metabolically driven alterations in BAT
thermogenesis and energy expenditure that contribute to over-
all energy homeostasis (Morrison et al., 2014). BAT thermo-
genesis contributes to the maintenance of body temperature
during cold exposure and to the elevated core temperature dur-
ing several behavioral states, including wakefulness, the acute
phase response (fever), and stress. BAT energy expenditure
requires metabolic fuel availability and contributes to energy
balance.
The consequences of the “thermoregulatory hypothesis” of
eating behavior are that subjects with a high set-point of body
temperature and/or low sympathetic activity are induced to eat a
high quantity of food to elevate the sympathetic discharge and
body temperature. Many studies (Keesey and Hirvonen, 1997;
Morrison et al., 2012b) indicate that some forms of obesity can
be regarded as instances of regulation at an elevated set point,
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while other forms seemingly result from a regulatory dysfunction,
as already reported by Keesey (1988).
Conversely, subjects with a low thermal set-point and/or a high
sympathetic tone need to introduce a lower quantity of food to
reach a preﬁxed thermal set-point. Alterations of postprandial
thermogenesis due to a reduced response of sympathetic acti-
vation can play an important role in inducing obesity. In other
words, subjects with a low postprandial sympathetic activation
need to introduce a higher quantity of foot to reach a preﬁxed body
temperature. On the other hand, being overweight increases the
sympathetic discharge that contributes to induce diseases related
to abnormal body weight (Lambert et al., 2010).
Chronic sympathetic over activity is also known to be present
in central obesity, and many evidences demonstrate the conse-
quence of a high sympathetic outﬂow to organs such as the heart,
kidneys, and blood vessels. Chronic sympathetic nervous system
over activity can also contribute to a further decline of insulin
sensitivity, creating a vicious cycle that may lead to the develop-
ment of the metabolic syndrome and hypertension. The cause
of this over activity is not clear, but may be driven by certain
adipokines (Smith and Minson, 2012). In addition, the postpran-
dial activation of the peripheral sympathetic nervous system is
fundamental to maintain energy balance. A contribution of post-
prandial sympathetic activation to the thermic effect of food is
not always evident and depends on the size and composition of
the meal, with carbohydrates having the clearest effect. Signals
related to food intake from various origins (e.g., gut, hepatopor-
tal area, chemoreceptors) are integrated in the brain and result
in increased peripheral sympathetic outﬂow. It is of interest to
emphasize the role of diet composition (according to the life
style of subjects) in the level of sympathetic activation during
the day in view of the potential role of adrenergic over activ-
ity in the pathogenesis of obesity and its metabolic syndrome
(Van Baak, 2008).
Power spectral analysis (PSA) of the heart rate variability
(HRV) is considered a non-invasive method for quantitative and
qualitative evaluation of the autonomic nervous system activity
in various ﬁelds of research and clinical studies. In the frequency
domain method of HRV, the high frequency (HF) component
is associated solely with parasympathetic activity. The low fre-
quency (LF) component is associated with both sympathetic and
parasympathetic activities, but sympathetic activity is the greater
contributor. LF power may correlate more with baroreﬂex func-
tion and/or stress that with the cardiac sympathetic innervations
(Moak et al., 2007; Shah et al., 2011).
This approach should modify the interpretations about the
sympathetic function in the pathophysiology of the obesity. In
a study conducted in our laboratory (Monda et al., 2006a), we
demonstrated that LF and HF values of premenopausal obese
women were lower than values of lean women. In postmenopause,
LF and HF have a comparable decline in lean and obese women,
as a consequence no difference can be found. These results suggest
a reduction of the vegetative modulation in obese young women
and the reduction of the autonomic control regards both the sym-
pathetic and parasympathetic components (Monda et al., 2006b).
The reduction of the sympathetic branch could be an impor-
tant factor in the maintenance of obesity in premenopausal age.
Indeed, a reduction in the sympathetic activity could be linked to
a low energy expenditure, so that a reduced energetic cost could
explain the higher body weight in premenopausal women. In this
experiment, the autonomic activity of postmenopausal women is
lower than that of premenopausal subjects, though a better indi-
cator of the sympathetic activity would be very low frequencies
(Fleisher et al., 1996). This indicates that the modiﬁcations of the
autonomic modulation cannot be included among factors related
to obesity in postmenopausal subjects. Many experimental evi-
dences have demonstrated that an increase in sympathetic and
thermogenic activity reduces food intake. Therefore, the obesity
can be due to an increase in food intake associated to a reduced
activity of the sympathetic nervous system. On the other hand,
a study revealed lower respiratory sinus arrhythmia, as evaluated
by the HF-HRV spectral analysis combined with deep breathing
tests, which points to the presence of cardiac vagal dysfunction in
obese adolescents (Tonhajzerova et al., 2008). Importantly, auto-
nomic imbalance with decreased parasympathetic activity maybe
the ﬁnal common pathway in numerous conditions associated
with increased morbidity and mortality (Thayer and Lane, 2007).
The evaluation of cardio respiratory interactions, in particular
the heart rate variability, can provide diagnostic information
about early subclinical autonomic dysfunction in obesity. Tra-
ditionally, there have been two hypotheses about the nature of
the predominate abnormality in SNS behavior in human obe-
sity. Bray (1991) used the acronym “MONA LISA” to describe
his hypothesis that Most Obesities kNown Are Low In Sympa-
thetic Activity. This vision was based principally on studies in
rodents that exhibited low SNS activity and morbid obesity fol-
lowing lesions in the ventromedial hypothalamus. As such, low
SNS activity was considered causal in the development of obesity.
In contrast, Landsberg (1986) viewed SNS activation targeting
the heart, blood vessels and kidneys as a critical relation to the
well documented relation between obesity and hypertension (Hall,
2003; Davy and Hall, 2004).
PARADOXICAL EATING BEHAVIOR: HYPERPHAGIA AND
HYPOPHAGIA BY OREXIN-A
Since orexin-A is able to induce both the activation of thermoge-
nesis and hyperphagia, Monda et al. (2003) tested the possibility
that a previous thermogenic activation induced by orexin-A can
modify eating behavior. Food intake and body temperature were
monitored in 24 h-fasting male Sprague-Dawley rats for 15 h
after food presentation during the dark period. Orexin-A was
injected into the lateral cerebral ventricle 6 h before food presen-
tation. Food intake and body temperature were controlled also
in rats receiving orexin-A at the same time of food presenta-
tion. Orexin-A caused the same elevation of body temperature
in both groups, while food intake was signiﬁcantly lower in the
group receiving orexin-A 6 h before food presentation in com-
parison to the other group. This study demonstrated that the
effects on food intake induced by orexin-A depend on the time
of food presentation. This suggest to revise the role of orexin-A
in the control of food intake. The name assigned to this peptide
was due to the strong increase in food intake after an orexin-A
administration, assigning a fundamental role in the induction
of food intake (Wolf, 1998; Shiraishi et al., 2000). The results
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of the above publication call for a re-discussion of this role,
underlining the importance of orexin-A in the control of the
sympathetic activity and body temperature, which in turn affects
food intake. An ICV injection of orexin-A induces an increase
in the sympathetic activity and in the body temperature inde-
pendently of food ingestion, that is reduced in the rats with a
delayed presentation of food. This suggests that the effects on
body temperature are prevalent with respect to eating behavior.
Then, orexin-A can induce hyperphagia, but also hypophagia,
contradicting the signiﬁcance of this name that assign a pri-
mary hyperphagic effect to this peptide. For this reason, orexin-A
cannot be considered a substance with a primary hyperphagic
effect.
Orexin-A can induce hypophagia or hyperphagia (Shiraishi
et al., 2000), but it always induces an activation of thermogen-
esis (Monda et al., 2004b, 2008b). We believe that this peptide
elevates the thermoregulatory set-point, inducing the reactions
to reach the new level of body temperature. The increase in
food intake, obtained in the rats with a non-delayed pre-
sentation of food, could be a reaction aimed to reach an
elevated body temperature. Indeed, food ingestion induces a
rise in body temperature due to postprandial thermogenesis
(De Luca et al., 1987; Tentolouris et al., 2006; Monda et al.,
2008a; Messina et al., 2012, 2013a). The hyperphagic effect
of orexin-A disappears when the body temperature is already
increased, so that a reduction in food intake can happen in this
condition.
Although selective activation of orexin neurons directly can
elicit eating behavior (Inutsuka et al., 2014), the above-reported
demonstrations support the idea that orexin-A controls body
temperature and subsequently eating behavior.
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